Marrone Bio Innovations, Inc. (MBII): Price and Financial Metrics
GET POWR RATINGS... FREE!
MBII POWR Grades
- MBII scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.89% of US stocks.
- The strongest trend for MBII is in Growth, which has been heading down over the past 31 weeks.
- MBII's current lowest rank is in the Value metric (where it is better than 13.46% of US stocks).
MBII Stock Summary
- With a market capitalization of $233,158,753, Marrone Bio Innovations Inc has a greater market value than only 24.97% of US stocks.
- As for revenue growth, note that MBII's revenue has grown 31.2% over the past 12 months; that beats the revenue growth of 82.99% of US companies in our set.
- The volatility of Marrone Bio Innovations Inc's share price is greater than that of 83.62% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to MBII, based on their financial statements, market capitalization, and price volatility, are STIM, BSQR, INSM, SREV, and AUTO.
- MBII's SEC filings can be seen here. And to visit Marrone Bio Innovations Inc's official web site, go to www.marronebio.com.
MBII Valuation Summary
- In comparison to the median Basic Materials stock, MBII's price/earnings ratio is 166.38% lower, now standing at -15.2.
- MBII's price/sales ratio has moved down 26.3 over the prior 97 months.
- MBII's price/sales ratio has moved down 26.3 over the prior 97 months.
Below are key valuation metrics over time for MBII.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MBII | 2019-11-12 | 5.2 | 40.2 | -6.1 | -7.2 |
| MBII | 2018-02-15 | 2.2 | -0.9 | -1.2 | -3.5 |
| MBII | 2016-03-11 | 3.2 | 3.5 | -0.5 | -1.1 |
| MBII | 2014-12-01 | 4.0 | 0.8 | -1.5 | -0.6 |
| MBII | 2014-11-06 | 4.6 | 1.0 | -1.7 | -0.8 |
| MBII | 2013-11-18 | 41.1 | 5.8 | -7.2 | -7.3 |
MBII Stock Price Chart Interactive Chart >
MBII Price/Volume Stats
| Current price | $1.41 | 52-week high | $2.90 |
| Prev. close | $1.26 | 52-week low | $1.06 |
| Day low | $1.26 | Volume | 568,800 |
| Day high | $1.42 | Avg. volume | 541,752 |
| 50-day MA | $1.54 | Dividend yield | N/A |
| 200-day MA | $1.64 | Market Cap | 247.18M |
Latest MBII News From Around the Web
Below are the latest news stories about Marrone Bio Innovations Inc that investors may wish to consider to help them evaluate MBII as an investment opportunity.
Marrone Bio Innovations, Inc. (MBII) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseMarrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Marrone Bio Innovations to Report Second Quarter 2021 Results on Monday, August 16 at 4:30 p.m. Eastern TimeDAVIS, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the second quarter ended June 30, 2021, after market close on Monday, August 16, 2021 at 4:30 p.m. Eastern time. Management will host an investor conference call at 4:30 p.m. ET (1:30 p.m. PT) on August 16, 2021 to discuss Marron |
Rizobacter and Marrone Bio Innovations Expand Strategic Alliance to Supply Novel Seed Treatment in BrazilPERGAMINO, Argentina and DAVIS, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Rizobacter -- a subsidiary of Bioceres Crop Solutions Corp. (NYSE: BIOX) and a global leader in sustainable solutions for agriculture -- and Marrone Bio (NASDAQ: MBII) (MBI) -- an international leader in sustainable bioprotection and plant health solutions -- today announced that Rizonema™, a biological seed treatment for nematodes and soil dwelling insects, will be offered for use in row crops in Brazil through an expande |
Where Do Hedge Funds Stand On Marrone Bio Innovations Inc (MBII)?After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of March 31st. The results of that effort will be put on display in this article, as […] |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWelcome back, traders! |
MBII Price Returns
| 1-mo | -15.06% |
| 3-mo | -16.07% |
| 6-mo | -27.69% |
| 1-year | 21.55% |
| 3-year | -31.22% |
| 5-year | 76.25% |
| YTD | 12.80% |
| 2020 | 23.76% |
| 2019 | -31.29% |
| 2018 | 33.64% |
| 2017 | -48.60% |
| 2016 | 94.55% |
Continue Researching MBII
Here are a few links from around the web to help you further your research on Marrone Bio Innovations Inc's stock as an investment opportunity:Marrone Bio Innovations Inc (MBII) Stock Price | Nasdaq
Marrone Bio Innovations Inc (MBII) Stock Quote, History and News - Yahoo Finance
Marrone Bio Innovations Inc (MBII) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...